Literature DB >> 11868765

Sensitivity to anti-tuberculosis drugs in HIV-positive and -negative patients in Addis Ababa.

M Demissie1, E Lemma, M Gebeyehu, B Lindtjorn.   

Abstract

A cross-sectional survey was conducted between 1 August and 31 December, 1998 in Addis Ababa, Ethiopia to determine the rate of primary drug resistance to anti-tuberculosis drugs and to investigate its possible association with HIV infection. Sputum culture, sensitivity to first-line anti-tuberculosis drugs and HIV testing were done for 236 sputum smear-positive pulmonary tuberculosis patients. Primary drug resistance level (single or multidrug resistance) had not changed significantly since 1994. Primary resistance occurred more often among HIV-positive than among HIV-negative patients. The association between drug resistance and HIV will have a serious impact in the control of tuberculosis because in recent years the prevalence of HIV has increased dramatically in Ethiopia. Therefore, further studies on drug resistance and HIV infection and the establishment of drug resistance surveillance are recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11868765     DOI: 10.1080/00365540110076822

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  14 in total

1.  India losing battle against multi drug resistant tuberculosis.

Authors:  Anjali Saxena; Udita Mukherjee; Ankita Dua; Rup Lal
Journal:  Indian J Microbiol       Date:  2012-12       Impact factor: 2.461

2.  Most common causes of natural and injury-related deaths in Addis Ababa, Ethiopia.

Authors:  Tufa Gemechu; Mihrete Tinsae; Senait Ashenafi; Victor Manuel Rodriguez; Alfredo Lori; Michelle Collins; Rosemary Hurford; Rahel Haimanot; Melissa Sandoval; Enawgaw Mehari; T Dianne Langford
Journal:  Pathol Res Pract       Date:  2009-03-24       Impact factor: 3.250

3.  Tuberculosis: current situation, challenges and overview of its control programs in India.

Authors:  Gursimrat K Sandhu
Journal:  J Glob Infect Dis       Date:  2011-04

4.  DOTS improves treatment outcomes and service coverage for tuberculosis in South Ethiopia: a retrospective trend analysis.

Authors:  Estifanos B Shargie; Bernt Lindtjørn
Journal:  BMC Public Health       Date:  2005-06-06       Impact factor: 3.295

Review 5.  Multidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and care.

Authors:  Fantahun Biadglegne; Ulrich Sack; Arne C Rodloff
Journal:  Antimicrob Resist Infect Control       Date:  2014-10-03       Impact factor: 4.887

6.  The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.

Authors:  Nicholas Ezati; Deus Lukoye; Eddie M Wampande; Kenneth Musisi; George W Kasule; Frank G J Cobelens; David P Kateete; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2014-12-19       Impact factor: 3.090

7.  Microscopic examination and smear negative pulmonary tuberculosis in Ethiopia.

Authors:  Tibebe Seyoum Keflie; Gobena Ameni
Journal:  Pan Afr Med J       Date:  2014-10-16

8.  Underreported threat of multidrug-resistant tuberculosis in Africa.

Authors:  Yanis Ben Amor; Bennett Nemser; Angad Singh; Alyssa Sankin; Neil Schluger
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

9.  A meta-analysis of drug resistant tuberculosis in Sub-Saharan Africa: how strongly associated with previous treatment and HIV co-infection?

Authors:  Asres Berhan; Yifru Berhan; Desalegn Yizengaw
Journal:  Ethiop J Health Sci       Date:  2013-11

10.  Prevalence and Drug Resistance Patterns of Mycobacterium tuberculosis among New Smear Positive Pulmonary Tuberculosis Patients in Eastern Ethiopia.

Authors:  Berhanu Seyoum; Meaza Demissie; Alemayehu Worku; Shiferaw Bekele; Abraham Aseffa
Journal:  Tuberc Res Treat       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.